Strategies to load therapeutics into polysaccharide-based nanogels with a focus on microfluidics: A review.
Adjuvants, Immunologic
/ chemistry
Animals
Carbohydrate Sequence
Drug Carriers
/ chemistry
Drug Compounding
/ methods
Gene Transfer Techniques
Humans
Hydrophobic and Hydrophilic Interactions
Immunity
/ drug effects
Microfluidics
/ methods
Nanogels
/ chemistry
Polysaccharides
/ chemistry
Static Electricity
Vaccines, Synthetic
/ chemistry
Drug loading methods
Microfluidics
Nanogels
Nanogels-based vaccines
Polysaccharides
Journal
Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156
Informations de publication
Date de publication:
15 Aug 2021
15 Aug 2021
Historique:
received:
11
02
2021
revised:
04
04
2021
accepted:
15
04
2021
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
16
10
2021
Statut:
ppublish
Résumé
Nowadays nanoparticles are increasingly investigated for the targeted and controlled delivery of therapeutics, as suggested by the high number of research articles (2400 in 2000 vs 8500 in 2020). Among them, almost 2% investigated nanogels in 2020. Nanogels or nanohydrogels (NGs) are nanoparticles formed by a swollen three-dimensional network of synthetic polymers or natural macromolecules such as polysaccharides. NGs represent a highly versatile nanocarrier, able to deliver a number of therapeutics. Currently, NGs are undergoing clinical trials for the delivery of anti-cancer vaccines. Herein, the strategies to load low molecular weight drugs, (poly)peptides and genetic material into polysaccharide NGs as well as to formulate NGs-based vaccines are summarized, with a focus on the microfluidics approach.
Identifiants
pubmed: 34044935
pii: S0144-8617(21)00506-3
doi: 10.1016/j.carbpol.2021.118119
pii:
doi:
Substances chimiques
Adjuvants, Immunologic
0
Drug Carriers
0
Nanogels
0
Polysaccharides
0
Vaccines, Synthetic
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
118119Informations de copyright
Copyright © 2021. Published by Elsevier Ltd.